Resultados de procura - Jonathan Reuning‐Scherer

  • Mostrando 1 - 2 Resultados de 2
Limitar resultados
  1. 1
    Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial

    Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial por Christopher Parker, Lin Zhan, Paul Cislo, Jonathan Reuning‐Scherer, Nicholas J. Vogelzang, Sten Nilsson, Oliver Sartor, Joe M. O’Sullivan, Robert E. Coleman

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study

    Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study por Sten Nilsson, Paul Cislo, Oliver Sartor, Nicholas J. Vogelzang, Robert E. Coleman, Joe M. O’Sullivan, Jonathan Reuning‐Scherer, Minghua Shan, Zhan Lu, Chris Parker

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: